- Home
- MPU vs VOR Comparison
MPU vs VOR Comparison
Compare MPU & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPU
- VOR
- Stock Information
- Founded
- MPU 1989
- VOR 2015
- Country
- MPU Singapore
- VOR United States
- Employees
- MPU N/A
- VOR N/A
- Industry
- MPU Transportation Services
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- MPU Consumer Discretionary
- VOR Health Care
- Exchange
- MPU Nasdaq
- VOR Nasdaq
- Market Cap
- MPU 51.4M
- VOR 203.0M
- IPO Year
- MPU 1998
- VOR 2021
- Fundamental
- Price
- MPU $1.15
- VOR $1.34
- Analyst Decision
- MPU
- VOR Strong Buy
- Analyst Count
- MPU 0
- VOR 7
- Target Price
- MPU N/A
- VOR $11.36
- AVG Volume (30 Days)
- MPU 161.0K
- VOR 1.1M
- Earning Date
- MPU 11-12-2024
- VOR 11-07-2024
- Dividend Yield
- MPU N/A
- VOR N/A
- EPS Growth
- MPU N/A
- VOR N/A
- EPS
- MPU N/A
- VOR N/A
- Revenue
- MPU $26,001,000.00
- VOR N/A
- Revenue This Year
- MPU N/A
- VOR N/A
- Revenue Next Year
- MPU N/A
- VOR N/A
- P/E Ratio
- MPU N/A
- VOR N/A
- Revenue Growth
- MPU 1444400.00
- VOR N/A
- 52 Week Low
- MPU $0.77
- VOR $0.63
- 52 Week High
- MPU $4.48
- VOR $2.60
- Technical
- Relative Strength Index (RSI)
- MPU 29.05
- VOR 56.75
- Support Level
- MPU $1.20
- VOR $1.05
- Resistance Level
- MPU $1.42
- VOR $1.76
- Average True Range (ATR)
- MPU 0.15
- VOR 0.19
- MACD
- MPU -0.03
- VOR 0.02
- Stochastic Oscillator
- MPU 0.00
- VOR 53.11
About MPU Mega Matrix Corp.
Mega Matrix Inc formerly Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.